First Tracks Biotherapeutics, Inc. (TRAX)
45.86
+2.38
(+5.47%)
USD |
NASDAQ |
Oct 27, 11:53
First Tracks Biotherapeutics Price : 45.86 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 43.10 | 45.42 | 41.83 | 43.48 | 592297.0 |
| Oct 23, 2026 | 43.13 | 44.78 | 41.60 | 44.05 | 849820.0 |
| Oct 22, 2026 | 42.27 | 44.14 | 41.67 | 43.14 | 844299.0 |
| Oct 21, 2026 | 41.20 | 42.89 | 40.00 | 42.77 | 711798.0 |
| Oct 20, 2026 | 36.67 | 41.78 | 36.28 | 41.25 | 1.034M |
| Oct 19, 2026 | 35.01 | 37.26 | 35.00 | 36.28 | 1.434M |
| Oct 16, 2026 | 37.07 | 37.24 | 33.38 | 34.46 | 1.041M |
| Oct 15, 2026 | 34.68 | 36.30 | 33.98 | 36.04 | 1.579M |
| Oct 14, 2026 | 31.28 | 34.32 | 30.88 | 34.13 | 982120.0 |
| Oct 13, 2026 | 33.72 | 34.36 | 31.12 | 31.68 | 1.115M |
| Oct 12, 2026 | 39.45 | 40.50 | 33.02 | 34.05 | 7.312M |
| Oct 09, 2026 | 31.96 | 33.28 | 30.71 | 31.85 | 855242.0 |
| Oct 08, 2026 | 33.31 | 33.31 | 30.11 | 32.01 | 1.483M |
| Oct 07, 2026 | 30.91 | 31.75 | 30.53 | 30.59 | 355525.0 |
| Oct 06, 2026 | 33.02 | 33.02 | 30.96 | 31.39 | 614109.0 |
| Oct 05, 2026 | 34.44 | 34.44 | 30.88 | 32.99 | 667813.0 |
| Oct 02, 2026 | 34.45 | 35.41 | 32.50 | 33.28 | 1.168M |
| Oct 01, 2026 | 35.20 | 36.02 | 33.77 | 33.92 | 564143.0 |
| Sep 30, 2026 | 36.74 | 37.31 | 35.32 | 35.44 | 610640.0 |
| Sep 29, 2026 | 36.61 | 36.80 | 34.99 | 35.98 | 645567.0 |
| Sep 28, 2026 | 34.40 | 37.24 | 33.55 | 36.64 | 674498.0 |
| Sep 25, 2026 | 35.82 | 35.82 | 33.66 | 34.42 | 356511.0 |
| Sep 24, 2026 | 36.11 | 37.09 | 34.57 | 35.83 | 1.144M |
| Sep 23, 2026 | 41.14 | 41.38 | 36.57 | 36.66 | 659442.0 |
| Sep 22, 2026 | 39.43 | 42.24 | 39.37 | 41.03 | 893221.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AnaptysBio, Inc. | 49.54 |
| Mirum Pharmaceuticals, Inc. | 84.04 |
| Biogen, Inc. | 251.07 |
| Immunovant, Inc. | 28.74 |
| Forte Biosciences, Inc. | 76.99 |
Price Related Metrics
| Price to Book Value | 9.615 |
| Earnings Yield | -10.78% |
| Market Cap | 1.623B |